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Abstract 
Small insertions and deletions (indels) and large structural variations (SVs) are 
major contributors to human genetic diversity and disease. However, mutation 
rates and characteristics of de novo indels and SVs in the general population 
have remained largely unexplored. We report 332 validated de novo structural 
changes identified in whole genomes of 250 families, including complex indels, 
retrotransposon insertions and interchromosomal events. These data indicate a 
mutation rate of 2.94 indels (1-20bp) and 0.16 SVs (>20bp) per generation. De 
novo structural changes affect on average 4.1kbp of genomic sequence and 29 
coding bases per generation, which is 91 and 52 times more nucleotides than de 
novo substitutions, respectively. This contrasts with the equal genomic footprint 
of inherited SVs and substitutions. An excess of structural changes originated on 
paternal haplotypes. Additionally, we observed a non-uniform distribution of de 
novo SVs across offspring. These results reveal the importance of different 
mutational mechanisms to changes in human genome structure across 
generations. 
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Introduction 
Genomic mutations drive human evolution and phenotypic diversity. Comparative 
genomics studies highlighted important small base-level and large-scale differences 
between human and chimpanzee genomes and noted a larger impact of segmental 
duplications compared to single nucleotide variations (SNVs) (Cheng et al. 2005). 
Whereas interspecies comparisons provide us with insight into long-range processes 
such as genetic drift and selection, the information derived from direct measurements of 
the de novo mutation spectrum and rates across generations is crucial for 
understanding mechanisms of mutation formation and inter-individual differences (Scally 
and Durbin 2012). While several projects have started to investigate the rates and 
characteristics of de novo SNVs (Michaelson et al. 2012; Francioli et al. 2014; Kong et 
al. 2012; Besenbacher et al. 2015), those of de novo short insertions and deletions 
(indels) and large structural variants (SVs) have been much less studied (Campbell and 
Eichler 2013). 
Copy number variations (CNVs) and SVs contribute substantially to human genetic 
variation (Korbel et al. 2007; Sebat et al. 2004; Iafrate et al. 2004; Tuzun et al. 2005) 
and the phenotypic impact of CNVs may be larger than of SNVs (Conrad et al. 2010; 
Stranger et al. 2007; Redon et al. 2006). The impact of novel changes in genome 
structure is further illustrated by their role in human genetic disease (Cooper et al. 2011; 
Stankiewicz and Lupski 2010). Copy number variations (CNVs) are widely studied and 
have been implicated in a variety of neurological disorders, such as autism (Sebat et al. 
2007), schizophrenia (Walsh et al. 2008) and intellectual disability (Cooper et al. 2011). 
Recent large-scale exome sequencing studies have uncovered de novo SNVs and short 
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indels causing various disease phenotypes, ranging from complex neurological disease 
to rare Mendelian disorders (Veltman and Brunner 2012). 
Given the significant contribution of de novo mutations to human disease and evolution, 
studying genome-wide mutation rates and patterns is important for understanding 
mutation origins, locating hotspots, estimating disease risk and interpreting novel 
disease-associated mutations. Here, we surveyed the entire spectrum of de novo indels 
(1-20bp) and SVs (>20bp) in the human population at nucleotide-resolution using whole 
genome sequencing data of 250 families from the Genome of the Netherlands (GoNL) 
project (Boomsma et al. 2014; Francioli et al. 2014). 
Results 
Study design and variant detection 
The Genome of the Netherlands project includes 231 parent-offspring trios, 11 quartets 
with monozygotic twins and 8 quartets with dizygotic twins for a total of 258 genetically 
distinct children. DNA material was obtained from peripheral blood mononuclear cells to 
avoid problems with accumulated somatic mutations routinely observed in DNA isolated 
from cell lines (Londin et al. 2011). The medium coverage (14.5x median sequence 
depth; 38.4x median physical depth) of paired-end sequencing data combined with a 
family-based design enabled the construction of a high-quality dataset of genomic 
variation (Francioli et al. 2014).  
Indels (1-20bp) were called using three different tools using information from gapped 
reads and split-reads (Fig. 1, Methods). We focused exclusively on variants that were 
detected only in a single child by at least one tool with high confidence (Supplemental 
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Table 1). We performed experimental validation assays for all 1,169 candidate de novo 
indels in 110 children from 92 families (11 quartets with monozygotic twin pairs, 7 
quartets with dizygotic twin pairs, 74 trios). We successfully re-sequenced 968 
candidates in these families, of which 291 indels (203 deletions, 74 insertions and 14 
complex indels) were confirmed as de novo events. All 31 de novo indels validated in 
monozygotic twin pairs were concordant between the two twins, showing that most of 
the mutations we report are germline mutations. After validation, we randomly excluded 
one of the twins from each monozygotic twin pair, leaving 99 children for de novo indel 
analysis. We only focused on regions where we had sufficient indel calling power by 
requiring at least 4 reads in the child and 10 reads in each parent. Using these 
thresholds a median of 77% of the genome was covered with sensitivity of 93.2% based 
on comparison of singletons in 11 twin pairs and 83.3% based on comparison of 
singletons in deep-coverage whole-exomes of 24 parents. This revealed a lower 
sensitivity for insertions (92.6% based on twin comparison, 75.1% based on whole-
exome comparison) than for deletions (93.5% based on twin comparison, 87.4% based 
whole-exome comparison).  
Structural variants (>20bp) were predicted by a selection of 11 tools that together use 
information from gapped reads, split-reads, discordant read-pairs and read depth to 
capture the full spectrum of SV sizes and types (Fig. 1, Methods). We identified a total 
of 601 de novo SV candidates in the 258 GoNL offspring based on permissive call 
settings and visual inspection using the Integrated Genome Viewer (IGV) (Robinson et 
al. 2011) (Supplemental Table 1). All candidates were subjected to experimental 
validation, resulting in a final set of 41 confirmed de novo SVs ranging in size from 20bp 
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to 327kbp (Supplemental Figs. 1, 2). The de novo SV set includes 27 deletions, 8 
tandem duplications, 5 retrotransposon insertions and 1 complex interchromosomal 
event (that also involves a retrotransposon segment). We estimate the sensitivity of our 
calling for SVs sized 20-99bp and SVs larger than 100bp to be 69.4% and 85.8% that of 
deep coverage data, respectively. Further, nearly the complete genome, (an average of 
98.8% of the haploid genome excluding assembly gaps) was covered by four or more 
read-pairs, a minimum threshold for calling SVs in our data (Methods). The sensitivity 
for detection of retrotransposon insertions was tested based on a previously published 
set of validated variants and found to be 77.6% for heterozygous retrotransposon 
insertions (Stewart et al. 2011). To empirically estimate the sensitivity for calling large 
SVs (>100 kb), we analyzed Illumina high-density SNP array data that were generated 
for 57 families (Supplemental Table 2). We detected a single de novo deletion (113 kb) 
in these data, which was already identified by whole genome sequencing. 
In total, we confirmed 332 de novo structural changes (291 indels of size 1-20bp and 41 
SVs larger than 20bp), which were used for downstream analyses (Fig. 2A, 
Supplemental Table 2). All 332 de novo variations are uniquely present in a single 
individual in the GoNL cohort. We also examined the overlap with public databases and 
found that 3 large SVs (>80% reciprocal overlap; Database of Genomic Variants; 1000 
Genomes Phase 1) and 8 rare indels (exact match; dbSNP build 142; allele frequency < 
1.5%) are overlapping, suggesting that these events might be recurring in the 
population (Supplemental Table 2). 
Indel and SV mutation rates 
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Previous estimates of the human indel mutation rate range from 0.53 to 1.5 x 10-9 per 
base per generation (Campbell and Eichler 2013; Kondrashov 2003; Lynch 2010; 
Besenbacher et al. 2015; Ramu et al. 2013). The mutation rate for copy number variants 
was estimated to be 0.03 CNVs larger than 500bp (Conrad et al. 2010) and 0.012 CNVs 
larger than 100kbp (Itsara et al. 2010) per haploid genome. Our data indicate a mutation 
rate of 0.68 x 10-9 indel (1-20bp) per base per generation and 0.08 SVs (>20bp) per 
haploid genome (or 0.16 SVs per generation). The higher SV rates reported here in 
comparison to previous array CGH studies result from greater power to interrogate the 
full size range and spectrum of structural changes (Fig. 2A). For example, when 
considering only CNVs larger than 500bp or larger than 100kbp our data provide a rate 
of 0.041 and 0.0077 per haploid genome, respectively. In addition, a substantial 
proportion (15%) of the de novo SVs were retrotransposition events, allowing us to 
empirically estimate the rate of retrotransposition in the population to 0.023 (1/43) per 
generation. This is in line with estimates based on diseased subjects and on 
comparative genomics studies (Belancio et al. 2008; Burns and Boeke 2012). 
Although the above de novo SV rate implies that only one in seven children bears such 
a mutation, we found six offspring with two and one with three de novo SVs 
(Supplemental Table 2). Such co-occurrence of multiple SVs is unexpected under a 
uniform distribution of the 41 de novo SVs across the 258 children (p = 0.0074). One 
individual carries two de novo deletions (327kbp and 1.5kbp) on maternal Chromosome 
18 within a distance of 202kb of each other. This close placement of two de novo SVs is 
unlikely to be random (p = 1.35 x 10-4). Together, these data suggest possible 
differences in the effects of environmental factors or the vulnerability for acquiring de 
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novo SVs per family (Conrad et al. 2011). We did not find evidence for a non-uniform 
distribution of the de novo indels across offspring (p = 0.061). 
Elevated paternal mutation rates 
Large-scale genome sequencing of families with disorders has shown that most de 
novo SNVs have a paternal origin, with a significant increase of de novo mutation 
burden with paternal age (Kong et al. 2012; Michaelson et al. 2012; Francioli et al. 
2014; Jiang et al. 2013; Conrad et al. 2011). In addition, the majority of sporadic de 
novo CNVs and cytogenetically balanced genomic rearrangements in patients with 
congenital disorders are paternal in origin (Hehir-Kwa et al. 2011; Batista et al. 1994). 
However, it is unclear whether this bias is also present for de novo SVs and indels 
occurring in the general population. Using reads spanning neighboring phase-
informative polymorphisms, we assigned a parental haplotype to 20% of the indels (39 
paternal, 20 maternal) and 71% of the SVs (20 paternal, 9 maternal). We observed a 
significantly larger fraction (66.1%) of indels and SVs arising on paternal chromosomes 
than on maternal chromosomes (pindel = 0.0092, pSV = 0.031, Fig. 2B), further 
emphasizing the contribution of the paternal germline to human mutations. There was 
no significant correlation between de novo structural change occurrence and paternal 
age, possibly due to the limited number of observations.  
Indel formation 
We found a total of 277 simple indels with a deletion to insertion ratio of 2.74:1.This ratio 
is consistent with previous reports (Montgomery et al. 2013; Bhangale et al. 2005), 
although it is possible that this number is influenced by differences in detection power 
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between insertions and deletions. To investigate the mechanisms of formation of these 
indels, we categorized their sequence content and flanking context (Table 1). Most of 
the de novo indels in our data (59.9%) were found in repeat regions or resulted in local 
copy count changes, meaning that the long allele can be obtained by copying part or all 
of the short allele. More specifically, we found 28 indels in homopolymer runs (HR), 27 
in tandem repeats (TR) and 111 indels resulting in a copy count change outside repeat 
regions (CCC). Copy-count-changing indels show a relatively balanced deletion to 
insertion ratio of 1.5:1. They likely arose through polymerase slippage, a process by 
which the leading and lagging strand become mispaired during DNA replication causing 
a few bases to be duplicated or deleted. Although we confirm a strong enrichment for 
indels in homopolymer runs (HR, p < 2.2 x 10-16) and tandem repeats (TR, p < 2.2 x 10-
16) (Montgomery et al. 2013), they only represent 19.9% of our observations. This is 
significantly less than what we observe in polymorphic indels in our data (44.2%) and in 
previous reports (46.0%, Montgomery et al. 2013), possibly indicating low selective 
pressures on these repetitive regions (Fig. 3A). 
The remaining 40.1% of the de novo indels occurred in non-repeat regions and did not 
lead to a copy count change (non-CCC). These likely result from imperfect double-
stranded DNA break repairs by non-homologous end-joining (NHEJ) which can create 
indels at the repair junction. Their very high deletion to insertion ratio of 12.9:1 supports 
their occurrence through NHEJ (Hastings et al. 2009). This provides a mechanistic 
explanation for the relative depletion of short insertions in the overall size spectrum of 
de novo variation (Fig. 2A). We found palindromic sequences (≤20bp away, ≥6bp long) 
flanking eight of these deletions, suggesting that a secondary structure such as a 
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hairpin loop played a role in their formation (Hastings et al. 2009; Montgomery et al. 
2013). Another five non-CCC indels presented microhomologies of at least 4bp, 
possibly indicating emergence through microhomology-mediated end joining (MMEJ) 
(McVey and Lee 2008). 
In addition to the 270 simple indels, we also identified 14 complex indels (Table 1 and 
Fig. 3B, Supplemental Table 3) replacing multiple bases (2-10bp) by a different 
sequence (1-11bp). Although similar types of complex indels have been described 
previously (Levy et al. 2007), this class of variants has largely been neglected in 
sequencing studies and is therefore absent from variant repositories. As they represent 
4.8% of the de novo indels in our data, we speculate that this type of polymorphism may 
be relatively common. Indeed, we found that 5.1% of inherited indels in the GoNL 
samples seem complex. One of the difficulties posed by such variation when studying 
polymorphisms is that they can be due to a combination of multiple separate indels or 
SNVs or as a single complex variant. We provide here the first de novo observation of 
such variations in humans, showing that they indeed arose as part of a single 
mutational event. 
In contrast to simple indels, only two complex indels are located in repetitive regions, 
indicating that polymerase slippage is unlikely to be a major contributor to their 
formation. Strikingly, five of them form palindromic repeats (≥6bp), a proportion 
significantly elevated when compared to simple insertions (p = 0.0015). The inserted 
bases for another three variants appeared to have been templated from the neighboring 
sequence. Such palindromic and templated complex indels have been reported in 
model organisms around double-stranded break repairs through synthesis-dependent 
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microhomology-mediated end joining (SD-MMEJ) (Yu and McVey 2010) and theta-
mediated end joining (TMEJ) (Roerink et al. 2014). The formation of these indels likely 
follows a multi-step process involving resection of break ends, hairpin formation, 
microhomology-mediated annealing and DNA synthesis. Fig. 3B shows an example of 
how a de novo complex event we observed could have arisen through SD-MMEJ. 
SV formation  
To obtain insights into the origin of de novo SVs in the general population, we 
experimentally fine-mapped their breakpoints at base-pair resolution and assigned a 
formation mechanism (Fig. 4A, Supplemental Table 2) (Lam et al. 2010). The majority 
(N = 24, 58.5%) of the SVs larger than 20bp likely arose via non-homologous repair 
(NHR) as their breakpoints presented little or no homology (0-6bp, N = 19) or short 
inserted sequences (1-18bp, N = 5). The breakpoints junctions of eight SVs (19.5%) 
contained long homologous sequences (28bp to 12kb) indicating formation by 
homology-driven repair and these are classified as mediated by non-allelic homologous 
recombination (NAHR) (Supplemental Table 2). Three variants (7.3%) were found 
within a region with a variable number of tandem repeats (VNTR).  
We also identified 6 de novo mobile element insertions (14.6% of SVs), all short 
interspersed elements (SINE) retrotransposon insertions of the AluY family 
(Supplemental Fig. 2, Supplemental Table 2). The sequences of the breakpoint 
junctions of the de novo AluY retrotransposon insertions all indicate the presence of 
target site duplication (TSD) of 3-16bp, and poly-A tails (Supplemental Fig. 2); both 
well-known signatures of retrotransposon integration (Burns and Boeke 2012). 
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Remarkably, in one instance of interchromosomal integration we found three breakpoint 
junctions leading to the joining of two small DNA fragments – one from Chromosome 3 
(163bp) and another from Chromosome 19 (179bp) – into Chromosome 4 (Fig. 4B). We 
propose that this complex rearrangement has also occurred through retrotransposition, 
because the fragment from Chromosome 19 contains part of an AluY element and no 
DNA is lost at the original genomic positions of the inserted sequences. Furthermore, 
the breakpoint on Chromosome 4 likely involved a staggered cut with three overhanging 
nucleotides, which appear as TSDs in the final product. The fragment on Chromosome 
3 is close (1.7 kbp) to the 3’UTR of the PPARG gene. We hypothesize that the fragment 
could represent a retrocopy of an RNA product from this region, e.g. an elongated 
version of the PPARG mRNA or another transcript. 
We compared the proportion of de novo SVs derived from each of four mechanisms 
with inherited SVs from the GoNL project. This revealed a larger proportion of mobile 
element insertions (MEI, 40.8%, p = 0.029) for inherited SVs and a lower proportion of 
NHR (30.3%, p = 0.0072), while similar proportions of VNTR (10.5%) and NAHR 
(18.4%) mediated variants were found. In addition, we compared the proportion of each 
SV mechanism with those reported previously (Mills et al. 2011; Pang et al. 2010, 2013; 
Kidd et al. 2010) (Supplemental Table 4) and found substantial differences between 
studies, which probably reflect methodological differences (Pang et al. 2013). 
Functional impact of de novo structural changes 
Although none of the de novo indels overlapped with protein-coding exons, in total 6 
large de novo SVs (3.7kbp – 327kbp) affect coding regions, resulting in exonic 
duplications of BANK1 (1 exon), PROC, GCNT3, GTF2A2 and BNIP2 (complete 
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genes), and deletions in LYN (1 exon), PTPRM (6 exons) and UBR5 (8 exons) (Fig. 5, 
Supplemental Table 2). Four SVs potentially disrupt gene function by changing reading 
frames, introducing premature stop codons or truncating the protein. Examination of 
these genes in the exome sequencing database from the Exome Aggregation 
Consortium (ExAC, http://exac.broadinstitute.org) revealed that all of them contain 
heterozygous loss-of-function mutations in the population. This indicates that 
heterozygous changes in these genes possibly have no early developmental 
consequences. Mutations in two of the affected genes - BANK1 and PROC - are 
associated with systemic lupus erythematosus (Kozyrev et al. 2008) and thrombophilia 
(Romeo et al. 1987), respectively. However, PROC and BANK1 duplications – as 
observed in our study – have not been reported to be associated with a clinical 
phenotype and the offspring carrying these de novo SVs appeared healthy at the time of 
sampling (aged 39 and 32).  
Next, we compared the genomic footprints of de novo SVs and indels with SNVs 
(Supplemental Methods). Consistent with recent studies involving families with 
disorders (Kong et al. 2012; Michaelson et al. 2012; Jiang et al. 2013; Gilissen et al. 
2014), an average of 45 de novo SNVs per child were detected in the GoNL Project 
(Francioli et al. 2014). While the cumulative burden of de novo indels was only 7.1bp 
per child, we found that despite their lower frequency de novo SVs affected on average 
4,084 genomic bases (Fig. 6A). This relatively large impact of SVs was also found in 
coding regions where an average of 28.6 coding bases per generation were affected by 
de novo SVs, while only 0.55 coding bases per generation were mutated by de novo 
SNVs (Fig. 6B). The larger number of affected bases for SVs relative to SNVs is largely 
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due to their difference in size. We observed that per offspring 18 times more genes are 
hit by de novo SNVs (0.55) versus SVs (0.03) (Fig. 6C). However, only 5% of de novo 
SNVs is potentially disruptive (stop gained, stop lost, splice-site change), whereas 50% 
(4/8) of the de novo SVs possibly have a major impact on gene structure and function 
(Fig. 5).  
Finally, we investigated differences in the genomic footprint of de novo and inherited 
SVs and SNVs identified in the GoNL data. We found that on average large de novo 
SVs (>20bp) affect 90.6 times more genomic bases, 52.0 times more coding bases and 
60.1 to 114.7 times more bases marked by histone modifications than de novo SNVs 
(Fig. 6D). In contrast, inherited SVs affected on average only 1.6 times more bases 
when compared to inherited SNVs. Altogether, these data demonstrate the overall 
impact of de novo SVs on the genome when compared to de novo SNVs and indels. 
Discussion 
The human genome continuously evolves as a result of mutation and selection. 
Because of the relatively low rate of SV and indel formation, large numbers of parent-
offspring families are required to capture the full spectrum of de novo changes that alter 
genome structure every generation (Campbell and Eichler 2013). Moreover, the 
detection and genotyping of these variants remain challenging given their diversity in 
both size and type (Alkan et al. 2011). Although limited by the short size of reads and 
the relatively low coverage depth used in this study, we have provided a representative 
picture of the landscape of de novo SVs and indels in the human genome based on 
whole-genome sequencing of 250 families by leveraging multiple calling approaches.  
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Our work demonstrates that both de novo indels and SVs originate primarily in the 
paternal germline, complementing recent findings on de novo SNVs (Kong et al. 2012; 
Michaelson et al. 2012; Francioli et al. 2014). We provide empirical estimates for the 
rate of de novo SVs and indels across the complete size spectrum, including relative 
frequencies of different variant sizes and types. These rates define a baseline for the 
general population and will help guide the interpretation of de novo indels and SVs in 
the diagnosis of individual patients (Stankiewicz and Lupski 2010). Roughly 15% of 
patients with intellectual disability or congenital abnormalities harbor an apparently 
causative CNV, most of which occur de novo (Hochstenbach et al. 2011). Estimating 
pathogenicity of these CNVs is based on their overlap with known disease CNVs, 
protein coding genes and control databases, but should also consider the background 
rate of large CNVs as described here. Specifically, we find that changes in gene 
structure - i.e. deletion or tandem duplication of entire exons - occur at a rate of 1 in 43 
offspring in the general population. 
In spite of their low frequency, large de novo SVs have a substantial impact on the 
genome. Due to their larger size, the average genomic footprint of de novo SVs is much 
greater than that of de novo SNVs and they are much more likely to hit a coding region. 
Indeed, 14.6% of the de novo SVs we observed affected exons, whereas only about 
1.3% of the de novo SNVs did. The considerable influence of de novo SVs is however 
primarily driven by a limited number of de novo SVs altering multiple kilobases of 
genomic sequence in a single generation. These rare but large variants may be quickly 
removed from the population by purifying selection, particularly when they hit genes or 
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other important genomic elements (Fig. 5) (Mills et al. 2011; Conrad et al. 2010). This 
may explain why inherited SVs and SNVs affect a similar number of bases. 
Previous studies have convincingly shown that large and dramatic genome changes 
introduced by large structural mutations can be associated with a multitude of 
pathological conditions (Stankiewicz and Lupski 2010). In this study we demonstrate 
that a broad range of de novo indels and structural variations is also characteristic for 
individuals obtained from a general human population.  
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Methods 
Whole genome sequencing and alignment 
Genomic DNA from nucleated blood cells was obtained from 250 Dutch families (231 
trios, 8 quartets with dizygotic twins and 11 quartets with monozygotic twins), which 
were selected without phenotypic ascertainment. Library construction and whole-
genome sequencing was performed using the Illumina HiSeq 2000 platform (500 bp 
insert size, 90bp paired-end reads).  
Reads were aligned to the GRCh37/hg19 human genome reference using BWA 0.5.9-
r164 (Li and Durbin 2009). We expect that alignment to GRCh38 would not significantly 
alter our findings, given that de novo variation is dependent on differences between 
parental and offspring genomes. Aligned data were processed following the Genome 
Analysis Toolkit (GATK) best practices v2 (DePristo et al. 2011): duplicate reads were 
marked using Picard tools (http://picard.sourceforge.net), reads were realigned around 
indels using GATK IndelRealinger and base quality scores were recalibrated using 
GATK BaseRecalibrator. Additional details regarding the study design, sequencing and 
alignment can be found in (Francioli et al. 2014). 
Detection of de novo variants 
Indels were called using GATK UnifiedGenotyper (DePristo et al. 2011) and Pindel (Ye 
et al. 2009) and all calls were further genotyped with GATK HaplotypeCaller 
(Supplemental Methods). We used GATK PhaseByTransmission (PBT) to call de novo 
variants from the GATK UnifiedGenotyper and HaplotypeCaller calls using a mutation 
prior of 10-4 per base per generation. We kept calls with (a) no evidence of the non-
reference allele in the parents, (b) no non-reference allele called in any other GoNL 
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sample, (c) at least 2 reads supporting the non-reference allele in the child, (d) a PBT 
posterior of at least Q20. Pindel calls with non-reference reads in the child only, at least 
2 reads supporting the non-reference allele in the child and no significant strand bias 
were kept as de novo candidates. All putative de novo indels from either method were 
experimentally validated in 92 of the families (including 7 quartets with dizygotic twin 
pairs). 
De novo SVs were called and filtered independently by 11 algorithms based on the 
following approaches: gapped/split read mapping (Pindel (Ye et al. 2009), GATK 
UnifiedGenotyper (DePristo et al. 2011), GATK HaplotypeCaller), analysis of discordant 
pairs (BreakDancer (Chen et al. 2009), 1-2-3-SV (http://tools.genomes.nl/123sv.html) 
(Kloosterman et al. 2011), Genome STRiP (Handsaker et al. 2011), MATE-CLEVER 
(Marschall et al. 2013)), read depth analysis (CNVnator (Abyzov et al. 2011), DWAC-
seq (http://tools.genomes.nl/dwac-seq.html), FACADE (Coe et al. 2010)). In addition, 
Mobster was used to call de novo mobile element insertions (MEIs) (Thung et al. 2014). 
For each algorithm, variant calls confined to kid(s) of a single family, but not detected in 
any other GoNL samples were selected and visually evaluated with IGV (Robinson et al. 
2011) to discard false positives due to alignment artifacts. We then created a union of all 
remaining calls by merging variants detected by multiple methods in the same child 
based on SV type and overlapping coordinates. We retained the most precise 
breakpoints for each variant based on the calling algorithm (in order: split-read, 
discordant read-pairs, read-depth). Local de novo assembly (SOAPdenovo (Luo et al. 
2012)) was used for breakpoint fine-mapping for SVs greater than 100bp. A detailed 
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description of the tools, settings, filtering and variant calls, including sensitivity analysis 
is provided in the Supplemental Methods. 
Experimental validation 
Oligonucleotide primers for amplification of a genomic segment containing the variant 
(for mutations smaller than 100bp) or variant breakpoints (for larger SVs) were designed 
using Primer3 software (Supplementary Table 2). PCR products were resequenced 
with Sanger, IonTorrent or MiSeq (2x250 bp) technologies. Genotyping of the 
resequenced variants is described in the Supplemental Methods. 
Parental origin 
We used genotypes from phased haplotypes (Francioli et al. 2014) to interrogate the 
parental origin of de novo indels and SVs. For indels, we identified read-pairs containing 
both the de novo allele and a phase-informative SNP allele.  
Parental haplotypes for SVs were determined from allele ratios at overlapping SNPs. 
Assignment to the paternal or maternal haplotype was made if: a) one or more 
homozygous alleles in the offspring are located inside a de novo deletion and could only 
be inherited from one parent; b) one or more polymorphic SNPs in offspring are located 
inside a de novo duplication and have a 2:1 (or 1:2) ratio with the reference allele and 
can be assigned unambiguously to either the paternal or maternal haplotype; c) a SNP 
in the offspring was located within a discordant read pairs supporting the de novo SV 
and could be assigned to either the paternal or the maternal genome. 
Paternal and familial biases 
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We tested for enrichment of de novo mutations on the paternal haplotypes using a one-
tailed binomial test and found that both indels (p = 0.0092) and SVs (p = 0.031) were 
indeed enriched. Additionally, we fit a linear model to the number of de novo indels in 
the 99 independent offspring and the father’s age at conception correcting for coverage 
but did not find a significant association (p = 0.24). 
We used a multinomial model with equal probability for each child to receive a de novo 
variant to test for uniform distribution of variants across children (goodness-of-fit p-value 
obtained using 100,000 Monte Carlo replicates). 
In one sample, we observed two SVs occurring on maternal Chromosome 18 at a 
distance of 201kbp. We computed the probability of observing 2 independent deletions 
so closely located by direct enumeration. Let E1 and E2 be the smaller and larger 
deletion events, respectively, having respective lengths of L1 and L2 bases. Neglecting 
edge effects at the ends of chromosomes, the number of ways E1 could be placed in the 
genome is (G - L2 + 1) – (L1 + L2 – 1), where G is the nominal genome size. The first 
term represents the possible placements of E1, the second the number of placements 
that would result in the collapse of both events. If D is the observed distance in bp 
between the two events, then the number of the total placements that are significant is 2 
D, since E1 could be on either side of E2 implying a “two-sided” test. The ratio of these 
two counts represents the tailed P-value. Given G ≈ 3 x 109 and the observed values L1 
= 1,552, L2 = 326,954, and D = 201,790, we find a P-value of 1.35 x 10-4. 
Computation of mutation rates 
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To compute the indel rate, we used validated de novo indels in 99 children from 92 
families, including 11 quartets with monozygotic (MZ) twins, 7 quartets with dizygotic 
(DZ) twins and 74 trios. We only used one child from each of the MZ twin pairs and 
considered the 14 children from the 7 DZ twin pairs as independent for this analysis. 
Using permutations, we ruled out any correlation between siblings from a DZ pair (p = 
0.59). The rate was computed as the sum of de novo indels divided by the sum of 
accessible bases in the 99 children. 
The SV rate was computed over 258 children from all 250 families. Only one child was 
considered for each of the monozygotic twin pairs and siblings from dizygotic twin pairs 
were considered as genetically independent with respect to de novo SVs. The rate was 
calculated by dividing the number of de novo SVs (N = 41) by the 258 children times 2 
transmitted haplotypes. We also report the rate for de novo MEIs (N = 6, including one 
interchromosomal event which involved an AluY element) computed in a similar fashion. 
Indel and SV formation mechanisms 
Indels were annotated using the classification proposed by Montgomery et al. 
(Montgomery et al. 2013), except for Predicted Hotspots (PR) that we did not use since 
they were not readily available and complex indels that are new in our data.  
Analysis of mutation formation mechanisms of SVs was performed using BreakSeq 
software v. 1.3 (Lam et al. 2010). See the Supplemental Methods for a full description 
of indel and SV classification. 
 
Data access 
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Sequence data have been deposited at the European Genome-phenome Archive 
(EGA), which is hosted by the European Bioinformatics Institute (EBI), and are available 
via https://www.ebi.ac.uk/ega/studies/EGAS00001000644. 
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Figure legends 
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Figure 1. Overview of study design. A total of 250 parent-offspring families were 
sequenced at 14.5x coverage. De novo indel and structural variant (SV) calling was 
performed using 11 algorithms combining gapped reads, split reads, discordant read-
pairs and read depth approaches to cover the entire mutation size spectrum. All 
candidate indels (1,169 in 99 children) and SVs (601 in 258 children) were subjected to 
experimental validation leading to 291 validated de novo indels and 41 de novo SVs. 
 
Figure 2. Frequency of de novo indels and SVs. (A) Size-frequency distribution of 
332 validated de novo indels and SVs identified in this study. In addition, the frequency 
of de novo SNVs is shown (Francioli et al. 2014). The asterisk denotes a size bin 
containing one de novo tandem duplication and six de novo retrotransposon insertions. 
(B) Barplot indicating the numbers of de novo indels and SVs on paternal and maternal 
haplotypes. 
 
Figure 3. Overview of de novo and inherited indel classes and their formation 
mechanisms. (A) Proportion of de novo and inherited indels by class. Inherited indels 
exhibit a 2.3 fold enrichment in indels located in homopolymer runs (HR) and tandem 
repeats (TR) when compared to de novo indels, suggesting lower selective pressures in 
these regions. (B) Outline of a plausible 7-step process that could account for the 
formation of a complex de novo indel by SD-MMEJ. 
 
Figure 4. Mechanisms contributing to the formation of de novo SVs. (A) Overview 
of four SV formation mechanisms, including examples and observed counts for each of 
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these. L=left flank; R=right flank; J=junction. (B) Schematic structure of a complex de 
novo interchromosomal SV involving an insertion of DNA from Chromosomes 3 and 19 
into Chromosome 4. TSD: target site duplication. 
 
Figure 5. Effect of de novo SVs on protein coding genes. (A) Deletion of 6 exons of 
PTPRM resulting in an in-frame shortened gene. (B) Deletion of 1 exon of LYN causing 
an out-of-frame effect at the transcript level. (C) Deletion of 5 exons of UBR5 causing an 
out-of-frame effect at the transcript level. (D) Duplication of 1 exon of BANK1, possibly 
resulting in a premature stop. (E) Duplication of the entire PROC1 gene. (F) Duplication 
of 3 entire genes (GCNT3, GTF2A2, BNIP2). Duplications are shown in green and 
deletions in red. A, ancestral allele; D, derived allele. 
 
Figure 6. Functional impact of de novo indels and SVs. (A) Average number of 
genomic bases affected by de novo SNVs, indels and SVs per child. (B) Average 
number of coding bases affected by de novo SNVs, indels and SVs per child. (C) 
Average number of genes affected by de novo SNVs, indels and SVs per child. The 
relative frequencies of the effects of the variations on the gene are indicated. (D) 
Comparison of the footprint of de novo (blue bars) and inherited (brown bars) large SVs 
(>20bp) relative to the footprint of SNVs. The footprint was computed genome-wide, in 
protein-coding regions and genomic regions marked by H3K4Me1, H3K4Me3 and 
H3K27ac based on data from the ENCODE project (The ENCODE Project Consortium, 
2007). The y-axis shows the ratio of the average number of affected bases per offspring 
relative to SNVs.  
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Table 1. Indel classes and mechanisms 
Class Example1 Observations Possible Mechanisms Sequence Features 
Homopolymer 
Run 
Ref.    CTGAGGAAGAGTTTTTTTTACA 
De Novo CTGAGGAAGAG-TTTTTTTACA 
21 insertions 
7 deletions 
Polymerase slippage Repeat context 
Tandem Repeats 
Ref.    CTACCCCAGGCAGAGAGAGAAA 
De Novo CTACCCCAGGC----AGAGAAA 
8 insertions 
19 deletions 
Polymerase slippage Repeat context 
Copy Count 
Changing 
Ref.    CAGAAGG----TAGCTAGTCAG 
De Novo CAGAAGGTAGCTAGCTAGTCAG 
37 insertions 
74 deletions 
Polymerase slippage  Local copy count change 
Non Copy Count 
Changing 
Ref.    CTAAAGGGCAGTCTTGCAAAAG 
De Novo CTAAAGGGCAG--TTGCAAAAG 
8 insertions 
90 deletions 
NHEJ2 Blunt or microhomolgy at breakpoints  
Ref.    AGTCAAAAACCAAAGTTTTGAA 
De Novo AGTCAAAAACCA---TTTTGAA 
8 deletions NHEJ2 / hairpin loop Palindrome (≥6bp) in surrounding context (≤20bp) 
Ref.    GGGGAGAATTGAGACTTGATCA 
De Novo GGGGAGAA-------TTGATCA 
5 deletions NHEJ
2
 / MMEJ3 / 
replication slippage 
Microhomology ≥4bp at 
breakpoints 
Complex 
Ref.    ACTCACAAAAAAATTTTTTTCC 
De Novo ACTCACAAAAA-TTTTTTTTCC 
2 variants Polymerase slippage Repeat context 
Ref.    CACATGGGCTTCC-----TGTC 
De Novo CACATGGGCTGGAGCCCATGTC 
8 variants 
SD-MMEJ4 
TMEJ5 
Palindromic or templated 
insertion 
Ref.    CCAAAGTGCTGGGATTACAGGC 
De Novo CCAAAGTGCTC-GATTACAGGC 
4 variants Unknown None 
1All examples are chosen from observed validated de novo indels and their positions are given with respect to the start of the variant on the human reference 
genome build 37. In the alleles column, “A” denotes the ancestral allele and “D” the derived allele. Differences between the ancestral and derived alleles are 
highlighted in bold. Repeats and palindromes are underlined with straight and wavy lines respectively. 
2NHEJ: Non-homologous end joining 
 2
3MMEJ: Microhomology-mediated end joining 
4SD-MMEJ: Synthesis-dependent microhomology-mediated end joining 
5TMEJ: Theta-mediated end joining 
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Figure 2
5’CAAATGTGCTTCATTTCAAACGAGC   TATTTTACCCACCTCTCTTCA 3’
3’GTTTACACGAAGTAAAGTTTGCTCG ATAAAATGGGTGGAGAGAAGT 5’
1. double-strand break at CG/TA
Red = deletion Green = insertion Blue = new synthesis 
2. 5’ to 3’ resection
5’CAAATGTGCTTCATTTCAAACGAGC A 3’
3’G ATAAAATGGGTGGAGAGAAGT 5’
3. snapback to form hairpin
A 3’
ATAAAATGGGTGGAGAGAAGT 5’
5’CAAATGTGCT
3’G
TCAT
GCAA
TT
ACCGA
5. unwinding of hairpin
5’CAAATGTGCTTCATTTCAAACGAGCACATTT A 3’
3’G ATAAAATGGGTGGAGAGAAGT 5’
6. anneal at ATTT/TAAA microhomology
5’CAAATGTGCTTCATTTCAAACGAGCACATTT A 3’
3’G TAAAATGGGTGGAGAGAAGT 5’A
4. limited synthesis (polQ?)
A 3’
ATAAAATGGGTGGAGAGAAGT 5’
5’CAAATGTGCT
3’G CGATTTACA
TCAT
GCAA
TT
AC
7. tail clipping, fill-in synthesis and ligation
5’CAAATGTGCTTCATTTCAAACGAGCACATTTTACCCACCTCTCTTCA 3’
3’GTTTACACGAAGTAAAGTTTGCTCGTGTAAAATGGGTGGAGAGAAGT 5’
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ATG  CTG  ...  CCA  G - AA  ACC  ...  TTT  TGA premature stop
...  AGG  CCA - AT CCA GAG ... out-of-frame
...  AGG  TAG - GA  CAG  ...out-of-frame
...  TTC  TCA  G - AT CCC ATG ... in-frame
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